NanoOntario is recognizing Emilio Alarcon, PhD, of the University of Ottawa Heart Institute with an award for outstanding early-career achievements in nano-related research and development. The scientist will accept his award and present a virtual lecture about his research, “ From chemical kinetics...
Search
Displaying 901 - 920 of 1414
Eddy Nason is an Elected Director of the Ottawa Heart Institute Research Corporation (OHIRC) Board of Directors.
Cardiovascular disease (CVD) is the country’s leading cause of premature death in women. The Canadian Women’s Heart Health Alliance (CWHHA), a national network of women’s heart health experts and advocates powered by the Canadian Women’s Heart Health Centre (CWHHC) at the University of Ottawa Heart...
Shoehorned into a small room, the first positron emission tomography (PET) scanner at the University of Ottawa Heart Institute made possible a dedicated PET imaging service for heart patients one day a week. That was in 1995, and cardiologist Rob Beanlands, MD, physicist Rob deKemp, PhD, and nuclear...
OTTAWA, February 6, 2024 — Media and the public are invited to learn about the current state of women's cardiovascular health in Canada and the actions that need to be taken to achieve equitable care in 2024. The Canadian Women's Heart Health Centre (CWHHC) at the University of Ottawa Heart...
With roughly half a million Canadians now living with heart failure, the condition is an increasingly common one that can seriously impact an individual’s quality of life. Even when appropriately treated, hospital admission and readmission rates are stubbornly high. George Wells, Director of the...
Dr. Pablo Nery is a staff cardiac electrophysiologist at the University of Ottawa Heart Institute (UOHI) and associate professor of medicine at the University of Ottawa.
Get ready for a night of heart healthy food, delicious wine, classical music and wonderful company On Thursday March 30, please join us for an elegant, fun-filled evening at the Shaw Centre in the Colonel By Foyer attached to the Westin Ottawa Hotel. Enjoy signature cocktails with colleagues and...
Networking events
Scheduled email service downtime The University of Ottawa Heart Institute will be migrating to a new email platform. As a result, you will not be able to reach us via email from Friday, January 29 at 9 p.m. to Monday, February 1 at 6 a.m. In case of an emergency, please contact the UOHI...
UOHI-led study demonstrates RIPK1 gene is associated with obesity, and silencing its expression is a viable therapeutic approach to obesity and related diseases. Watch: Dr. Katey Rayner discusses her research. Scientists at the University of Ottawa Heart Institute have demonstrated that elevated...
Scientist in the Division of Cardiac Surgery, and Director of the Bio-Nanomaterials Chemistry and Engineering Laboratory at the University of Ottawa Heart Institute Dr. Emilio Alarcon has been named a recipient of nearly $200,000 in research funding from the New Frontiers in Research Fund’s 2018...
Scientist in the Division of Cardiac Surgery, and Director of the Bio-Nanomaterials Chemistry and Engineering Laboratory at the University of Ottawa Heart Institute Dr. Emilio Alarcon has been named a recipient of nearly $200,000 in research funding from the New Frontiers in Research Fund’s 2018...
Arrhythmias — disturbances of the heart’s normal rhythm—affect more than 1.5 million Canadians and can impact a person’s health and well-being in a variety of ways. Sudden cardiac death caused by an arrhythmia kills 40,000 people every year. An estimated 350,000 Canadians are living with atrial...
Canadian Women’s Heart Health Alliance and Canadian Cardiovascular Society partner on clinical practice update on MINOCA.
More than half a million Canadians are living with heart failure and another 50,000 join their ranks each year. The standard treatment for heart failure has not changed for quite some time. Now, a new drug—so new that it’s identified only as LCZ696—is generating interest among cardiologists and...
Not all treatments work in all patients, but often it’s not possible to know ahead of time who will benefit. The Ottawa Heart Institute recently became the first centre in Canada to use a new radioactive tracer clinically to better define the prognosis of a patient in heart failure. The tracer...
The Heart Institute has played a pivotal role toward preventing a serious complication following open-chest surgery by helping launch Rhythm Biotherapeutics Inc.
The University of Ottawa Heart Institute (UOHI) is leading Canada's first dedicated walking rehabilitation program for people with peripheral arterial disease (PAD), a painful and debilitating “hardening” of the arteries outside of the heart, most commonly in the legs. The first-of-its-kind...
This study, conducted by experts at the Heart Institute, is featured in Circulation